Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuhiro Shibata

Showing results (21-30 of 335) with videos related to

Pageof 34
Sort By:
Expert Opinion on Emerging Drugs|December 21, 2013
Emerging drugs for biliary cancerTakuji Okusaka, Hidenori Ojima, Chigusa Morizane, et al.
The American Journal of Pathology|May 27, 2004
Cytoplasmic p120ctn regulates the invasive phenotypes of E-cadherin-deficient breast cancerTatsuhiro Shibata, Akiko Kokubu, Shigeki Sekine, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinomaTatsuhiro Shibata, Makoto Chuma, Akiko Kokubu, et al.
Carcinogenesis|October 27, 2025
Eighty years of cancer research after the atomic bombings of Hiroshima and NagasakiJonathan M Samet, Preetha Rajaraman, Sharon R Pine, et al.
Histopathology|August 21, 2013
Inflammatory myofibroblastic tumour of the lung with a novel PPFIBP1-ALK fusion variantAkihiko Yoshida, Tatsuhiro Shibata, Koji Tsuta, et al.
European Journal of Preventive Cardiology|August 28, 2025
Peripheral vs. Central Arterial Stiffness and Cardiovascular Events in Older Adults: The Atherosclerosis Risk in Communities (ARIC) studyTatsuhiro Shibata, Yejin Mok, Shoshana H Ballew, et al.
Cancer Science|June 14, 2013
Histological factors for accurately predicting first locoregional recurrence of invasive ductal carcinoma of the breastTakahiro Hasebe, Motoki Iwasaki, Takashi Hojo, et al.
NPJ Systems Biology and Applications|May 13, 2026
tugMedi: simulator of cancer-cell evolution for personalized medicine based on the genomic data of patientsIurii Nagornov, Eisaku Furukawa, Momoko Nagai, et al.
Pancreas|September 16, 2004
Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activityPanayiotis Loukopoulos, Kengo Kanetaka, Masaaki Takamura, et al.
Japanese Journal of Clinical Oncology|April 24, 2014
Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinomaHiroyuki Takahashi, Hidenori Ojima, Hiroko Shimizu, et al.
Pageof 34

Showing results (21-30 of 335) with videos related to

Sort By:
Pageof 34
Expert Opinion on Emerging Drugs|December 21, 2013
Emerging drugs for biliary cancerTakuji Okusaka, Hidenori Ojima, Chigusa Morizane, et al.
The American Journal of Pathology|May 27, 2004
Cytoplasmic p120ctn regulates the invasive phenotypes of E-cadherin-deficient breast cancerTatsuhiro Shibata, Akiko Kokubu, Shigeki Sekine, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinomaTatsuhiro Shibata, Makoto Chuma, Akiko Kokubu, et al.
Carcinogenesis|October 27, 2025
Eighty years of cancer research after the atomic bombings of Hiroshima and NagasakiJonathan M Samet, Preetha Rajaraman, Sharon R Pine, et al.
Histopathology|August 21, 2013
Inflammatory myofibroblastic tumour of the lung with a novel PPFIBP1-ALK fusion variantAkihiko Yoshida, Tatsuhiro Shibata, Koji Tsuta, et al.
European Journal of Preventive Cardiology|August 28, 2025
Peripheral vs. Central Arterial Stiffness and Cardiovascular Events in Older Adults: The Atherosclerosis Risk in Communities (ARIC) studyTatsuhiro Shibata, Yejin Mok, Shoshana H Ballew, et al.
Cancer Science|June 14, 2013
Histological factors for accurately predicting first locoregional recurrence of invasive ductal carcinoma of the breastTakahiro Hasebe, Motoki Iwasaki, Takashi Hojo, et al.
NPJ Systems Biology and Applications|May 13, 2026
tugMedi: simulator of cancer-cell evolution for personalized medicine based on the genomic data of patientsIurii Nagornov, Eisaku Furukawa, Momoko Nagai, et al.
Pancreas|September 16, 2004
Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activityPanayiotis Loukopoulos, Kengo Kanetaka, Masaaki Takamura, et al.
Japanese Journal of Clinical Oncology|April 24, 2014
Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinomaHiroyuki Takahashi, Hidenori Ojima, Hiroko Shimizu, et al.
Pageof 34